Xbrane Biopharma AB
STO:XBRANE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xbrane Biopharma AB
STO:XBRANE
|
SE |
|
Dawn Corp
TSE:2303
|
JP |
|
Diamcor Mining Inc
XTSX:DMI
|
CA |
|
One Liberty Properties Inc
NYSE:OLP
|
US |
|
FIH Mobile Ltd
HKEX:2038
|
CN |
|
Greenbriar Capital Corp
XTSX:GRB
|
CA |
|
Southern Michigan Bancorp Inc
OTC:SOMC
|
US |
Wall Street
Price Targets
XBRANE Price Targets Summary
Xbrane Biopharma AB
According to Wall Street analysts, the average 1-year price target for
XBRANE
is 11.22 SEK
with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is XBRANE's stock price target?
Price Target
11.22
SEK
According to Wall Street analysts, the average 1-year price target for
XBRANE
is 11.22 SEK
with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.
What is Xbrane Biopharma AB's Revenue forecast?
Projected CAGR
16%
For the last 12 years the
compound annual growth rate for
Xbrane Biopharma AB's revenue is
75%.
The projected
CAGR
for the next 2 years is
16%.
